NCT05758909 - Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation | Biotech Hunter

Enrollment

585

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions

Aortic Valve DiseaseAortic Valve StenosisHeart Valve Diseases

Interventions

DEVICE

TF TAVI

Follow-up Observation of patients having received a TF-TAVI

Trial Locations (13)

15006

RECRUITING

Hospital Universitario A Coruña, A Coruña

15706

RECRUITING

Hospital Clinico Universitario de Santiago, Santiago de Compostela

28040

RECRUITING

Hospital Clinico San Carlos, Aravaca

29010

RECRUITING

Hospital Regional Universitario de Malaga, Málaga

31008

RECRUITING

Hospital Universitario de Navarra, Pamplona

33011

RECRUITING

Hospital Universitario Central de Asturias, Oviedo

41013

RECRUITING

Hospital Universitario Virgen Del Rocio, Seville

46026

RECRUITING

Hospital Universitari i Politècnic la Fe, Valencia

03010

RECRUITING

Hospital General Universitario Dr. Balmis, Alicante

08916

RECRUITING

Hospital Universitari Germans Trias I Pujol, Badalona

08025

RECRUITING

Hospital de Santa Creu I Sant Pau, Barcelona

08035

RECRUITING

Hospital Universitari Vall Hebron, Barcelona

08907

RECRUITING

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors

lead

Fundación EPIC

OTHER